A BIS / EAR matter: evidencing the absence of control in practice

A mid-size precision-components exporter receives a notice from BIS. A foreign customer – one with which it has traded for years – has appeared on the Entity List. The exporter's compliance team assumes the matter is straightforward: the company does not own the listed entity and has no seat on its board. Surely the connection is remote enough. It is not.

Evidencing the absence of control in a BIS / EAR case requires more than a denial. It requires a structured, documented argument that dismantles each indicator BIS uses to establish a control relationship. The Export Administration Regulations (the rules administered by the Bureau of Industry and Security under the US Department of Commerce) do not treat ownership as the only route to control. Influence over purchasing decisions, technology access, and management appointments can each, independently, sustain a finding of control – and each must be addressed on the evidence.

This case comment walks through a representative matter in which an exporter faced exactly this challenge: an Entity List adjacency that threatened to shut down a significant product line. It covers the facts that created the problem, the legal questions that had to be resolved under the EAR, the evidence-building strategy deployed, and the lessons that apply to any business handling a comparable BIS / EAR issue.

The situation: an Entity List designation and an unexpected control question

The exporter – a European manufacturer of precision machined components with significant US-origin content in its production process – sold to a regional distributor. That distributor held exclusive resale rights in its territory and placed orders across multiple product lines. When BIS added the distributor to the Entity List, the exporter's immediate concern was the export-licence requirement that attached to each future shipment. That was the visible problem. The deeper problem emerged during the initial compliance review.

The distributor's corporate documents showed that the exporter's parent had, several years earlier, provided a short-term working-capital facility to the distributor. The facility had been repaid. But the facility agreement had contained a covenant requiring the distributor to obtain the lender's consent before changing its senior management. That covenant had never been formally unwound, even after repayment. BIS's analysis of control does not simply follow ownership lines. Contractual rights that give one party meaningful influence over another party's commercial or operational decisions are relevant to the control question, as are supply arrangements that create practical dependency.

The exporter faced a question it had not anticipated: did the residual covenant, combined with the commercial dependency created by the exclusive distribution arrangement, mean that BIS could characterise the exporter – or its parent – as exercising control over the listed entity? If so, the consequences would extend well beyond the licence requirement. They could reach into the parent's own standing with BIS.

The legal question: what does "control" mean under the EAR?

Under the EAR, the concept of control is not confined to equity ownership. BIS applies a functional analysis that looks at the practical reality of the relationship. The formal question is whether one person has the power to direct or cause the direction of the management and policies of another, whether through ownership, contract, or conduct.

This matters because the Entity List is a licensing tool, not only a designation. A party's placement on the list triggers a licence requirement for specified items – with a general policy of denial for many categories. But where a separate party is found to act in concert with, or under the effective direction of, a listed entity, BIS may treat that separate party as operating within the listed entity's orbit. The distinction between an arm's-length commercial counterparty and a controlled affiliate is therefore outcome-determinative.

The exporter's advisers had to examine four questions. First, did the expired facility agreement retain any operative effect? Second, did the exclusive distribution contract give the exporter practical control over the distributor's purchasing or pricing decisions? Third, had there been any conduct – communications, instructions, shared personnel – that a reviewing authority could read as direction? Fourth, were there any US-person connections in the exporter's own corporate structure that would bring the analysis squarely within the EAR's reach for dealings that were already covered by reason of US-origin content?

The cross-regime comparison was also material. Under OFSI's ownership-and-control test, and under the EU's asset-freeze rules, the control inquiry similarly looks beyond legal ownership to actual influence. What distinguishes the BIS / EAR context is the linkage between the control question and export-licence policy: a control finding does not merely freeze assets, it potentially closes the export channel altogether and triggers review of prior shipments.

How was the BIS / EAR issue resolved?

The resolution turned on the quality and completeness of the documentary record assembled to refute each control indicator. This is a point that cannot be overstated in BIS / EAR matters: the absence of control is not a default position that BIS accepts without support. It is a proposition that the party asserting it must prove, on the documents.

The advisers worked through a structured evidence-building exercise. The expired facility agreement was reviewed alongside the full correspondence history. The review confirmed that the covenant had not been invoked at any point during the facility's life, that no management change had been referred to the lender for consent, and that the repayment had been accompanied by a written confirmation discharging all obligations. That confirmation had not been formally executed as a deed of release – a gap that required a supplementary legal analysis confirming its binding effect under the governing law.

The distribution agreement was then reviewed against the same control standard. The agreement gave the distributor discretion over pricing within its territory, over customer selection, and over staffing. The exporter could set minimum quality standards and required the distributor to stock a minimum product range, but it could not direct day-to-day operations. Those provisions mattered. The advisers produced a written memorandum mapping each provision against the relevant BIS control indicators and explaining, clause by clause, why the agreement did not cross the control threshold.

The third strand was a conduct review. Six years of correspondence between the exporter's commercial team and the distributor was examined for any instruction, direction, or approval that went beyond what a normal arm's-length supplier would issue. Several emails gave initial concern: they included language that, read without context, could appear directive. In each case, the full exchange demonstrated that the communication was a product-specification query or a logistics coordination message, not a management instruction. Those emails were annotated and included in the evidence bundle.

The evidence package was presented to counsel for an independent assessment before any submission was made to BIS. That step is advisable in any matter of this complexity: an internal review team has institutional knowledge that can blind it to the appearance a document creates when read by an external reviewer without that context. In our experience, the most important function of external review at this stage is to identify the documents that create the worst impression – not the best ones.

What went wrong in this evidencing the absence of control matter?

Several things had gone wrong before the matter reached us. They are worth examining individually, because each is a pattern we see regularly.

The first failure was document hygiene. The facility agreement had been allowed to remain in force in name after its operative obligations had been discharged. No one had thought to execute a formal release. Legal instruments do not expire simply because the commercial relationship they governed has ended. Where a covenant gives one party rights over another's management decisions, that covenant should be formally discharged the moment those rights are no longer needed – not left on the file as an untidy loose end.

The second failure was contract review on a risk basis. The distribution agreement had been reviewed at inception by the exporter's commercial legal team. That review focused on commercial risk: liability caps, termination rights, intellectual property. It did not include a sanctions and export-control lens. An agreement that creates operational dependency – exclusive supply, minimum purchase obligations, shared technology access – should be reviewed against the control indicators in the relevant regime, not only against commercial risk.

The third failure was the absence of a periodic counterparty review. The distributor had changed ownership twice in the years since the distribution agreement was signed. Neither change had triggered a fresh compliance assessment. BIS / EAR compliance obligations are not static at the point of contract signature. The entity that holds a contract today may be a different entity, in the relevant regulatory sense, from the entity that signed it. Ownership changes, control changes, and listing events all require a fresh look.

These failures are not unusual. In our practice advising exporters across the major regimes, the same three gaps – document hygiene, contract review, and counterparty refresh – account for the majority of the situations in which a business finds itself needing to evidence the absence of control rather than simply confirm it.

Risk flags and when to involve compliance counsel

The following indicators should prompt an immediate review. They are not an exhaustive list. They are the patterns that, in a BIS / EAR context, most reliably signal that a control question may arise.

• A counterparty appears on the Entity List, the Denied Persons List, or any other BIS restricted-party instrument, and the company has a pre-existing contractual relationship with it.
• A counterparty's ownership changes and the incoming shareholder is associated with a jurisdiction or sector subject to heightened BIS scrutiny.
• An existing agreement contains covenants, approval rights, or step-in provisions that could be read as giving the company direction over the counterparty's management or purchasing decisions.
• The company's commercial team has been providing technical or operational assistance to the counterparty that goes beyond standard product support.
• US-origin content in the company's products means that the EAR applies to exports and re-exports, including re-exports by the counterparty.
• The company has personnel embedded at the counterparty's premises, or the counterparty regularly accesses the company's controlled technology remotely.

Counsel should be involved before any response to BIS is prepared. The temptation to write a short explanatory letter confirming that the company does not control the listed entity – without first assembling the underlying evidence – is one that must be resisted. A letter that makes the assertion without the evidence does not resolve the question; it creates a record of the assertion that BIS will then test against whatever documents it reviews.

The same principle applies to voluntary self-disclosures. Where a company identifies that it has shipped to a listed entity in the period between listing and discovery, the question of whether to make a VSD (voluntary self-disclosure, a submission to BIS identifying and describing the apparent violation) requires advice on the full factual record, including the control question. A VSD that is incomplete – that discloses the shipments but does not address the control position – can raise as many questions as it answers.

Is the business operating in a sector where BIS scrutiny is elevated – advanced semiconductors, precision manufacturing, certain chemicals? If so, the control standard applied in any review is likely to be exacting. The advisers' task is to meet that standard on the documents, not to argue around it.

What is the lesson for similar businesses: avoiding a repeat

The central lesson from this matter is one that applies across BIS / EAR evidencing the absence of control risk examples and compliance failure patterns: the evidence base that resolves a control question cannot be assembled in response to a regulatory notice. It must exist already, in usable form, at the point the notice arrives.

That means three things in practice. First, legacy contracts should be reviewed against the current regime's control indicators, not only against commercial risk. Any provision that gives the company approval rights, veto powers, or step-in rights over a counterparty's management or commercial decisions should be assessed for its regulatory effect and, where possible, restructured or formally discharged.

Second, counterparty refreshes should be triggered not only by screening hits but by ownership changes, changes in key management, and material changes in the counterparty's operating territory or customer base. A counterparty that was low-risk at contract signature may have moved into a higher-risk position through events entirely unrelated to your commercial relationship with it.

Third, the export-control classification of the goods involved should be confirmed and documented. Where items carry a non-EAR99 ECCN (Export Control Classification Number under the US Commerce Control List), the licensing analysis is more complex, and the consequences of a control finding are correspondingly more serious. Businesses that rely on EAR99 status without having formally confirmed it are operating on an assumption, not a conclusion.

The broader cross-regime point is this. The control question arises in different forms across OFAC, OFSI, the EU asset-freeze rules, and BIS / EAR. The analytical framework differs between regimes – OFAC's 50 percent rule is mechanical, while OFSI and the EU look at actual influence, and BIS focuses on functional direction. But the evidentiary discipline required is common to all of them. Where a company faces a control question under any of these regimes, the quality of its documentary record is the single most important variable in the outcome.

We have acted for exporters, manufacturers, and trading groups facing exactly this type of challenge under BIS / EAR and the parallel regimes. The work is document-intensive and requires a clear-eyed view of what the evidence actually says – not what the client's commercial team believes it says. For a confidential review of a potential BIS / EAR control question, or to discuss a compliance programme designed to prevent these situations arising, contact Calder & Vance at info@caldervance.com.

Related practices

• Evidencing absence of control – OFAC service – the OFAC parallel to the BIS / EAR analysis covered here
• Evidencing absence of control under BIS / EAR – practitioner guide – step-by-step procedural guide to the evidentiary process

This publication is general information and does not constitute legal advice. For advice on your situation, contact info@caldervance.com.